We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-5.25%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$578B
AUM Growth
-$88.6B
Cap. Flow
+$4.3B
Cap. Flow %
0.74%
Top 10 Hldgs %
34.17%
Holding
14,706
New
1,657
Increased
4,873
Reduced
6,001
Closed
1,835

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.96%
2 Technology 2.07%
3 Consumer Discretionary 1.49%
4 Financials 1.12%
5 Communication Services 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TUSK icon
11201
Mammoth Energy Services
TUSK
$149M
$192K ﹤0.01%
90,003
-15,922
-15% -$28.9K
CTV
11202
DELISTED
Innovid Corp.
CTV
$191K ﹤0.01%
+31,590
New +$173K
SBII.U
11203
DELISTED
Sandbridge X2 Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
SBII.U
$191K ﹤0.01%
19,407
GAPA.U
11204
DELISTED
G&P Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
GAPA.U
$191K ﹤0.01%
19,170
-745
-4% -$7.47K
BHR
11205
CALL
Braemar Hotels & Resorts
BHR
$139M
$190K ﹤0.01%
30,800
-3,600
-10% -$20.6K
EIM
11206
Eaton Vance Municipal Bond Fund
EIM
$493M
$190K ﹤0.01%
16,549
+4,627
+39% +$56.6K
NMR icon
11207
Nomura Holdings
NMR
$30.1B
$190K ﹤0.01%
44,987
-51,575
-53% -$233K
TELA icon
11208
TELA Bio
TELA
$31.4M
$190K ﹤0.01%
16,380
-3,471
-17% -$42K
CHB
11209
DELISTED
Global X China Biotech Innovation ETF
CHB
$190K ﹤0.01%
+16,484
New +$201K
LOKM.U
11210
DELISTED
Live Oak Mobility Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-fifth of one warrant
LOKM.U
$190K ﹤0.01%
19,184
AVO icon
11211
Mission Produce
AVO
$1.13B
$189K ﹤0.01%
14,943
-72,888
-83% -$971K
AXDX
11212
PUT
DELISTED
Accelerate Diagnostics
AXDX
$189K ﹤0.01%
13,120
-2,270
-15% -$64.6K
FHTX icon
11213
PUT
Foghorn Therapeutics
FHTX
$356M
$189K ﹤0.01%
12,400
-28,300
-70% -$388K
CMRX
11214
CALL
DELISTED
Chimerix, Inc.
CMRX
$189K ﹤0.01%
41,300
-147,700
-78% -$823K
ACRS icon
11215
PUT
Aclaris Therapeutics
ACRS
$885M
$188K ﹤0.01%
+10,900
New +$149K
ADMA icon
11216
PUT
ADMA Biologics
ADMA
$2.09B
$188K ﹤0.01%
102,800
-326,900
-76% -$510K
IGIC icon
11217
CALL
International General Insurance
IGIC
$1.13B
$188K ﹤0.01%
24,400
+1,400
+6% +$10.7K
SJB icon
11218
CALL
ProShares Short High Yield
SJB
$45.5M
$188K ﹤0.01%
10,400
-1,300
-11% -$23.4K
PWSC
11219
CALL
DELISTED
PowerSchool Holdings, Inc.
PWSC
$188K ﹤0.01%
+11,400
New +$183K
VBIV
11220
CALL
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$188K ﹤0.01%
3,783
+2,410
+176% +$119K
CGEN icon
11221
PUT
Compugen
CGEN
$246M
$187K ﹤0.01%
58,200
-5,400
-8% -$18.2K
DX
11222
Dynex Capital
DX
$3.2B
$187K ﹤0.01%
11,526
+381
+3% +$6.15K
HOOK
11223
CALL
DELISTED
HOOKIPA Pharma
HOOK
$187K ﹤0.01%
+8,200
New +$147K
ULCC icon
11224
CALL
Frontier Group Holdings
ULCC
$1.34B
$187K ﹤0.01%
16,500
-13,800
-46% -$173K
ZYME icon
11225
CALL
Zymeworks
ZYME
$2.02B
$187K ﹤0.01%
28,600
-4,600
-14% -$41K

Similar funds

Jeff Yass's Q1 2022 Portfolio in Review

As of Q1 2022, Jeff Yass held 14,706 positions worth $578B, down 13% from $667B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jeff Yass's Q1 2022 filing shows 1,657 new, 4,873 increased, 6,001 reduced and 1,835 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M. The largest sale was Walt Disney, an estimated $498M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q1 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.98B increase.
  • Jeff Yass's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $498M.
  • Jeff Yass fully exited Xilinx Inc in Q1 2022, selling an estimated $217M.
  • Jeff Yass's ten largest holdings make up 34% of its $578B portfolio in Q1 2022.
  • Jeff Yass opened 1,657 new positions and closed 1,835 in Q1 2022.
  • Jeff Yass's portfolio value fell 13% quarter-over-quarter to $578B.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.